We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Personal Screen | LSE:PSP | London | Ordinary Share | GB0003486585 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.085 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:4432Y Personal Screening PLC 15 February 2006 Personal Screening plc Placing and Admission to Trading on AIM First Day of Dealings Personal Screening (or "the Company"), a supplier of a range of self-test medical kits and the UK's leading supplier of CE approved home testing kits for detecting acute and chronic health and medical conditions, announces that it shares were admitted to trading on AIM today. The Company has raised gross funds of #799,500 by way of a placing of 79,500,000 New Ordinary Shares of 0.1p each at 1p per share. At the placing price, Personal Screening will have a market capitalisation of #1,443,832 on Admission. The number of Ordinary Shares in issue immediately following Admission is 144,383,198 Ordinary Shares of 0.1p each. The percentage of Enlarged Share Capital being placed pursuant to the placing is 55.1 %. The Company's shares have been trading on OFEX since 3 January 2001 and the Group has been trading in its current form since November 2003 when it acquired Personal Screening International Limited (formerly Personal Screening Limited). The Company is seeking admission to AIM in order to take advantage of the market's wider investor base, greater liquidity and better access to retail and institutional investors. The proceeds of the fundraising are to provide market support for its current range of products, to introduce new tests and to develop new trading relationships with other retail outlets. The Directors of Personal Screening believe that no other company has a larger range of branded approved tests. Commenting, Simon Driscoll, Managing Director, Personal Screening, said: 'A quotation on AIM will raise the Company's profile and enhance credibility. Personal Screening is about to embark on the next stage of its growth. We have worked hard to develop the widest range of approved self test medical kits in the UK and been encouraged by the level of interest expressed in the Group's products. Our restructured operations and new supply arrangements have reduced the cost-base significantly. The new infrastructure allows us to support higher levels of sales with only marginal increases in overhead. Part of the proceeds of the Placing will be used to retain the services of a medical PR and marketing company to ensure that a steady news-flow is directed towards key elements of the consumer media to build brand integrity and awareness. Key objectives will be to develop new products, to build on Government initiatives and raise consumer consciousness and, to develop strategic partnerships aimed at exploring new routes to market.' SP Angel is broker to the Company and Nabarro Wells is Nominated Advisor. Michael Scorey, who is currently Non-executive Chairman, will become Executive Chairman subsequent to the appointment of a new Non-executive Director. Aniz Visram will join the board as Finance Director with immediate effect. Placing Statistics Placing Price 1 pence Number of existing Ordinary Shares 64,433,198 Number of New Ordinary Shares being sold pursuant to the Placing 79,950,000 Percentage of Enlarged Issued Share Capital being Placed 55.1% Estimated gross proceeds of the Placing #799,500 Estimated net proceeds of the Placing receivable by the Company #595,000 Market capitalisation following the Placing at the Placing Price #1,443,832 Ticker Symbol PSP Enquiries Personal Screening Michael Scorey 020 7225 2163 Executive Chairman Simon Driscoll 01384 350 222 Managing Director Financial PR Binns & Co PR Ltd Peter Binns 07768 392 582 Chris Steele 07979 604 687 Binns & Co PR Ltd www.binnspr.co.uk Broker Phil O'Connell 020 7422 4300 SP Angel Nominated Advisors Keith Smith 020 7710 7403 Nabarro Wells Jonathan Naess 020 7710 7400 Nabarro Wells This information is provided by RNS The company news service from the London Stock Exchange END MSCILFEIFEIELIR
1 Year Personal Screening Chart |
1 Month Personal Screening Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions